Needham Raises Equifax (EFX) Price Target to $210
Key Points
- Needham reiterated its Buy rating on Equifax Inc. on October 21, 2026, lifting its price target to $210 from $190.
- Needham's $210 price target implies 19.40% upside from Equifax Inc.'s ($EFX) current $175.88 share price.
- Equifax shares recently traded around $175.88, sitting below its average analyst price target of $198.40.
- Other Wall Street firms recently updated their outlooks on the credit reporting agency, including BMO Capital and Stifel.
Since the rating, $EFX is up 5.2% to date (from the $175.57 close on Oct 21, 2026).
Get Equifax text alerts
We text you when insiders, Congress, analysts or big funds move on $EFX.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Equifax Inc. alert may contain errors. Disclosures
On October 21, 2026, Needham maintained its Buy rating on Equifax Inc. (NYSE: EFX) while lifting its price target from $190.00 to $210.00. The research note was issued as the credit reporting and data analytics firm navigated a busy week of Wall Street updates. Equifax closed at $15.57 on the day of the announcement.
EFX
Equifax Inc.
Needham's Call on Equifax Inc.
Needham kept its positive stance on the stock with a Buy rating and raised its target to $210.00 from $190.00. The decision follows a series of updates from other major financial institutions covering the consulting services provider.
Other Institutional Activity in Equifax Inc.
Large investment firms adjusted their holdings in Equifax leading up to the recent reports. Harris Associates L.P. reduced its holdings by 82,070 shares, ending with 7,447,263 shares worth about $1,390,888,069. Capital International Investors grew its holdings by 1,510,145 shares, ending with 5,187,147 shares worth about $968,777,506. Soroban Capital Partners LP grew its holdings by 226,382 shares, ending with 4,410,883 shares worth about $823,798,560. Massachusetts Financial Services Co. reduced its holdings by 830,486 shares, ending with 3,869,490 shares worth about $722,685,297. Brown Advisory Inc. reduced its holdings by 360,872 shares, ending with 3,287,984 shares worth about $614,080,329.
Equifax Inc. Stock Up 0.2%
Equifax shares recently traded around $175.88 as of October 22, 2026, sitting up about 0.2% from their event-day close of $175.57. The stock trades about 5.4% above its 50-day moving average of $166.89 and roughly 1.3% below its 200-day moving average of $178.27. Over the past year, the shares have traded as low as $137.01 and as high as $238.94.
$EFX price target
Equifax Inc. daily closes and this analyst's $210 target. Not advice.
Recent Earnings
Equifax reported trailing-twelve-month revenue of $6.59 billion alongside earnings of $6.18 per share. The company operates with a net profit margin of 11.3% and a return on equity of 15.4%. The next quarterly earnings report is scheduled for release on February 3, 2027.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
3 target cuts vs 0 raises.
-
EPS & revenue
EPS beat estimates by 8.3%. Revenue beat estimates by 1.0%.
-
Profit surprise
EBITDA met by 2 percent. Operating income met by 1 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
3 target cuts.
-
Earnings quality
Gross margin down 1.0 points. Operating margin up 1.1 points. Positive free cash flow.
Earnings Call Summary
Equifax had a strong first quarter with revenue of $1.649 billion up 14 percent and earnings per share of $1.86 up 22 percent, both ahead of expectations. The big driver was U.S. mortgage revenue which jumped 38 percent, boosted by new Work Number Indicator products and strong mortgage activity in February before interest rates rose. Management is excited about their artificial intelligence driven products and record numbers of pending patents, but they are holding full year guidance steady due to concerns about the Iran conflict and rising interest rates dampening mortgage demand over the rest of the year.
Guidance Equifax reaffirmed its full year 2026 guidance of about $6.745 billion in revenue and $8.54 in earnings per share despite strong first quarter results. Management kept guidance steady because of economic uncertainty tied to the Iran conflict and interest rate volatility, which pressured mortgage volumes in March and April. They still expect mortgage revenue to grow over 20 percent for the full year and diversified markets to grow in the high single digits.
Very weak report. The release materially worsened the forward outlook.
Dividend
Equifax pays an annual dividend of $2.24 per share, translating to a dividend yield of 1.28%. The payout ratio stands at 35.3% of earnings.
Insider Buying and Selling at Equifax Inc.
Company insiders executed several transactions earlier in the year. On May 1, 2026, Chief Operating Officer John W Gamble Jr sold 3,500 shares at an average price of $176.54 for a total value of $617,890. On May 7, 2026, Officer Chad M Borton sold 2,455 shares at an average price of $173.89 for a total value of $426,900. On July 24, 2026, Chief Executive Officer Mark W. Begor sold 37,791 shares for a total value of $6,506,255. Later, on September 3, 2026, John W Gamble Jr sold 4,500 shares at an average price of $187.96 for a total value of $845,820.
Analysts Set New Price Targets
Wall Street firms have actively adjusted their views on the stock. On October 16, 2026, Oppenheimer downgraded the stock to a Perform rating. On October 19, 2026, Mizuho maintained an Outperform rating while adjusting its price target from $210.00 to $185.00. On October 21, 2026, BMO Capital maintained a Market Perform rating and raised its target from $160.00 to $175.00. On the same day, Stifel maintained a Buy rating while lowering its target from $235.00 to $217.00. Across the broader analyst community, Equifax holds a consensus buy rating with a mean price target of $198.40 based on 20 analyst opinions.
About Equifax Inc.
Based in Atlanta, Georgia, Equifax operates as a global data, analytics, and technology company. The firm provides information solutions and workforce services to businesses and consumers through its Workforce Solutions, U.S. Information Solutions, and International segments. Its data services support lending, financial verification, and risk management decisions.
Bottom Line
Investors will look toward the company's next earnings release on February 3, 2027, for further updates on financial performance. Market participants continue to monitor how shares trade relative to analyst consensus targets.
Related Filing Alerts
Source: Needham's rating change on $EFX (Oct 21, 2026). Written by software, not financial advice. How we make alerts